noubar afeyan

GZERO event highlights: IMF chief, G7 vaccine pledges, global health security

GZERO event highlights: IMF chief, G7 vaccine pledges, global health security

For IMF Managing Director Kristalina Georgieva (above), a two-track pandemic means a two-track recovery that'll hurt the entire world in the long run. That's why she anticipates G7 leaders meeting this week will commit to sending about one billion doses of COVID vaccines to the developing world by the end of the year in new financing and shots unused by wealthy nations. Georgieva hopes it'll be a summit that gives all countries "a fair short in the arm, a fair shot at the future." Georgieva was one of many experts who joined this week's two-part livestream discussion about post-pandemic health security hosted by GZERO Media in partnership with Flagship Pioneering, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.

How will we deal with the next pandemic?

How will we deal with the next pandemic?

While most of the world is still grappling with COVID, some countries — mostly wealthy ones with early access to vaccines — are thinking about preparing for the next pandemic. This sentiment ties into a wider debate about health security that was missing when the virus hit us all early last year. Indeed, we should aspire to ensure the health security of our population instead of waiting for it to get sick, Flagship Pioneering CEO Noubar Afeyan said on June 9, during a live discussion, Stronger Partnerships for a Healthier World: Mutually Assured Protection — the second in GZERO Media's two-part discussion, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.

Let's learn from COVID to prevent the next pandemic

Let's learn from COVID to prevent the next pandemic

Days before G7 leaders meet in the UK to talk about how to "build back better" after the pandemic, experts are warning them that they should not lose sight of the opportunity to learn from the experience of COVID to be more prepared when the next public crisis hits. Below are a few insights from a livestream discussion between political leaders, policy makers, health experts and scientists, entitled Beyond the Pandemic: A Radical New Approach to Health Security, hosted by GZERO Media in partnership with Flagship Pioneering.

Beyond the Pandemic: A Radical New Approach to Health Security

Watch our live event: global health beyond the pandemic

Could the biggest health crisis of our lifetimes actually lead to a healthier world? Watch the second part of our live event series about what public health will look like after the COVID-19 pandemic, presented in partnership with Flagship Pioneering, the bio-platform company that founded Moderna and dozens of other life sciences firms. Days before world leaders G7 meeting, we will bring political leaders and policy makers together with health experts and scientists to discuss lessons learned from and the latest innovations to preempt both COVID-19 variants and future infectious disease pandemics.

Register to join: two-day event on health beyond the pandemic

Register to join: two-day event on health beyond the pandemic

As the world works toward a post-pandemic state, join GZERO Media on June 8 and 9 for a two-part live event on health security, in partnership with Flagship Pioneering (which founded Moderna). Days before this year's G7 meeting, we will bring political leaders and policy makers together with health experts and scientists to discuss lessons learned from and the latest innovations to preempt both COVID-19 variants and future infectious disease pandemics. The virtual event will be hosted by Noubar Afeyan, founder & CEO of Flagship Pioneering, and Ian Bremmer, president and founder of Eurasia Group and GZERO Media.

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

GZERO World Clips

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

Does the arrival of Moderna’s vaccine mean we’re back to normal?

GZERO World Clips

Does the arrival of Moderna’s vaccine mean we’re back to normal?

"I think we're going to live with the pandemic for much of 2021, but I don't think it's a binary thing where we have a pandemic and everything's awful, or the pandemic's gone and everything is great again." Noubar Afeyan, co-founder of the COVID-19 vaccine manufacturer Moderna, levels with Ian Bremmer that even with a vaccine the pandemic will not be gone in a matter of day, weeks, or even months. But that doesn't mean that everything will be as bleak as it may feel now. Their conversation was part of the latest episode of GZERO World.

What are the “known unknowns” about Moderna’s vaccine?

GZERO World Clips

What are the “known unknowns” about Moderna’s vaccine?

Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Moderna’s co-founder Noubar Afeyan on the growing pushback against a COVID-19 vaccine

GZERO World Clips

Moderna’s co-founder Noubar Afeyan on the growing pushback against a COVID-19 vaccine

"In any debate, if one side has to offer facts and the other side can offer doubts and they're considered of equal value, then the ones who offer doubts will always have an advantage." Moderna co-founder Noubar Afeyan isn't naïve about the pushback that his company's COVID-19 vaccine will receive when it hits the US market. Disinformation around vaccine safety and efficacy was rampant even before the pandemic began. His conversation with Ian Bremmer was part of the latest episode of GZERO World.